Sorivudine: Phase II data

In the Phase II ARYS-0502 trial, twice-daily treatment with ARYS-01 cream led to a 30%

Read the full 155 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE